Alphabet(US:GOOG) CNBC·2025-12-23 12:46Group 1: Novo Nordisk and Obesity Treatment - Novo Nordisk received FDA approval for the first-ever obesity treatment pill, set to launch early next year at a starting dose of 1.5 milligrams for $149 per month [7] - The approval is seen as a landmark decision that could expand access for patients suffering from obesity [1] - Following the news, shares of Novo Nordisk surged by 7%, while competitor Eli Lilly's shares fell by over 1% as it attempts to launch its own obesity pill [7] Group 2: Paramount and Warner Bros. Discovery - Paramount Skydance secured the backing of billionaire Larry Ellison in its bid for Warner Bros. Discovery, addressing concerns about financing from WBD's board [2][3] - WBD investors face a decision to either accept a sale to Netflix or tender their shares to Paramount, with potential implications for shareholder value [3] Group 3: Alphabet and Data Center Acquisition - Alphabet announced its acquisition of data center company Intersect for $4.75 billion in cash, which includes assuming its debt, aimed at enhancing data center capacity [5] Group 4: Janus Henderson Acquisition - Trian Fund Management and General Catalyst are set to acquire asset manager Janus Henderson for $49 per share, valuing the company at approximately $7.4 billion, with shares rising over 3% following the announcement [6] Group 5: Electric Vehicle Market Trends - The initial excitement around electric vehicles (EVs) has diminished, with legacy automakers now prioritizing traditional trucks and SUVs over EVs due to unmet demand expectations [9][10] Group 6: Instacart Pricing Strategy - Instacart announced the end of its AI-driven pricing tests after consumer concerns about price discrepancies for identical items, indicating a shift in its pricing strategy [11][12]